Alejandro Ferraz Do Prado

Adjunct Professor at the Institute of Biological Sciences, Federal University of Pará (UFPA). Pharmacist with a Master's and Ph.D. in Pharmacology. Completed a postdoctoral fellowship at the Emílio Goeldi Museum of Pará. At UFPA, he coordinates the Laboratory of Pharmacology and Toxicology of the Cardiovascular System (LAFTSC-UFPA). His primary research interests focus on elucidating the mechanisms involved in cardiac and vascular dysfunction mediated by matrix metalloproteinases 2 (MMP-2) and 9 (MMP-9) in cardiovascular diseases. He is also interested in bioproducts with pharmacological action for the treatment of hypertension, atherosclerosis, and heart failure. Supervises masters and doctoral students in the following graduate programs: Graduate Program in Biology of Infectious and Parasitic Agents (PPGBAIP-UFPA), Pharmacology and Biochemistry (FARMABIO), Pharmaceutical Sciences (PPGCF-UFPA), and the Graduate Program in Biodiversity and Biotechnology (BIONORTE). In 2016, he received the IASH/COH New Investigator Travel Award for Central and South American Trainees, awarded to 10 young researchers selected by the American Heart Association, the world's leading cardiovascular society. In 2023, he was elected an affiliate member of the Brazilian Academy of Sciences (ABC). In 2024, he was recognized as a CAPES Distinguished Fellow. He is a member of the following scientific societies: the Brazilian Academy of Sciences (ABC), the American Heart Association (AHA), and the American Physiological Society (APS). Coordinator of the CNPq research group in Cardiovascular Pharmacology and Toxicology. Research group website: dgp.cnpq.br/dgp/espelhogrupo/4265494777592692. (Source: Lattes Curriculum)